3-(2-Chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one

In the title molecule, C11H11ClN2O, the pyrido[1,2-a]pyrimidine ring system is planar (maximum deviation = 0.0148 Å) and the methyl C and carbonyl O atoms are nearly coplanar to it. The chloroethyl side chain is in a synclinal conformation, nearly orthogonal to the pyrimidine ring, with a dihedral angle between the chloroethyl side chain and the pyrimidine ring of 88.5 (1)°. Weak intermolecular C—H⋯N and C—H⋯Cl hydrogen bonds along with π–π interactions between the pyrimidine and pyridine rings [centroid–centroid distance is 3.538 (2) Å] form a three-dimensional network. The crystal is a racemic twin with a 0.68 (12):0.32 (12) domain ratio. MOPAC AM1 and density functional theory (DFT) theoretical calculations at the B3-LYP/6–311+G(d,p) level support these observations.

[1]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[2]  S. Nikitin,et al.  Synthesis, chemical and biological properties of pyrido[1,2-a]pyrimidines , 1994 .

[3]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[4]  John M. Burke,et al.  Optimization of an anti-HIV hairpin ribozyme by in vitro selection. , 1993, The Journal of biological chemistry.

[5]  H. Flack,et al.  On enantiomorph‐polarity estimation , 1983 .

[6]  J. F. Wolfe,et al.  Synthesis and anticonvulsant evaluation of some new 2-substituted-3-arylpyrido[2,3-d]pyrimidinones. , 2004, Bioorganic & medicinal chemistry.

[7]  M. Erion,et al.  Adenosine kinase inhibitors. 6. Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides and related compounds. , 2005, Journal of medicinal chemistry.

[8]  Joanna Stanley,et al.  Imidazo[1,2-a]pyrimidines as Functionally Selective and Orally Bioavailable GABAAα2/α3 Binding Site Agonists for the Treatment of Anxiety Disorders , 2006 .

[9]  E. Novellino,et al.  Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity. , 2007, Journal of medicinal chemistry.

[10]  El Mokhtar Essassi,et al.  2‐Méthyl‐3‐(3‐méthyl‐1H‐pyrazol‐5‐yl)pyrido[1,2‐a]pyrimidin‐4‐one , 2002 .

[11]  N. Blaton,et al.  Structure of 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidino]ethyl}-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (risperidone) , 1993 .

[12]  A. Becke.  Density-functional thermochemistry. III. The role of exact exchange , 1993 .

[13]  G. Spalluto,et al.  7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility. , 2002, Journal of medicinal chemistry.

[14]  E. De Clercq,et al.  Synthesis and Antiviral Activity of the alpha-Analogues of 1,5-Anhydrohexitol Nucleosides (1,5-Anhydro-2,3-dideoxy-D-ribohexitol Nucleosides). , 1997, The Journal of organic chemistry.

[15]  Warren J. Hehre,et al.  AB INITIO Molecular Orbital Theory , 1986 .

[16]  B. E. Zaitsev,et al.  Crystal structure and spectral characteristics of 2-methyl-3-chloro-9-hydroxypyrido[1,2-a]pyrimidin-4-one and bis(2-methyl-3-chloro-9-hydroxypyrido[1,2-a]pyrimidin-4-onium) perchlorate , 2004 .

[17]  A. Becke,et al.  Density-functional exchange-energy approximation with correct asymptotic behavior. , 1988, Physical review. A, General physics.

[18]  Xin-jun Liu,et al.  Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists. , 2004, Journal of medicinal chemistry.

[19]  A. Giannini,et al.  CLINICAL THERAPEUTIC CONFERENCE: Dopaminergic/Serotoneric Actions of Phencyclidine as a Model for Schizophreniform Psychosis , 1997, American journal of therapeutics.

[20]  G. Sheldrick.  A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[21]  B. Sridhar,et al.  3-(2-Chloro­ethyl)-2-methyl-4-oxo-6,7,8,9-tetra­hydro-4H-pyrido[1,2-a]pyrimidin-1-ium chloride , 2006 .

[22]  Deanne K. Thompson,et al.  Studies on pyrrolopyrimidines as selective inhibitors of multidrug-resistance-associated protein in multidrug resistance. , 2004, Journal of medicinal chemistry.